Current News Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses 2023-11-29 04:00:00 Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study 2023-11-29 04:00:00 Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study 2023-11-29 04:00:00 Mitigating secondary disaster triggered by fear of COVID-19: the role of professional medical societies Mitigating secondary disaster triggered by fear of COVID-19: the role of professional medical societies 2023-11-29 04:00:00 Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial 2023-11-29 04:00:00 Pagination First page « First Previous page ‹ Previous … Page 2003 Page 2004 Page 2005 Page 2006 Current page 2007 Page 2008 Page 2009 Page 2010 Page 2011 … Next page Next › Last page Last »
